The Treatment Results of a Standard Algorithm for Choosing the Best Entry Vessel for Intravenous Port Implantation.
Vascular cutdown and echo guide puncture methods have its own limitations under certain conditions. There was no available algorithm for choosing entry vessel. A standard algorithm was introduced to help choose the entry vessel location according to our clinical experience and review of the literature. The goal of this study is to analyze the treatment results of the standard algorithm used to choose the entry vessel for intravenous port implantation.During the period between March 2012 and March 2013, 507 patients who received intravenous port implantation due to advanced chemotherapy were included into this study. Choice of entry vessel was according to standard algorithm. All clinical characteristic factors were collected and complication rate and incidence were further analyzed.Compared with our clinical experience in 2006, procedure-related complication rate declined from 1.09% to 0.4%, whereas the late complication rate decreased from 19.97% to 3.55%. No more pneumothorax, hematoma, catheter kinking, fractures, and pocket erosion were identified after using the standard algorithm. In alive oncology patients, 98% implanted port could serve a functional vascular access to fit therapeutic needs.This standard algorithm for choosing the best entry vessel is a simple guideline that is easy to follow. The algorithm has excellent efficiency and can minimize complication rates and incidence.
From the Department of Surgery, Division of Thoracic and Cardiovascular Surgery (W-CW, C-YW, C-FW, T-WS, S-YY, T-CK, P-JK); and Department of Internal Medicine, Division of Chest and Critical Care, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan (J-YF).
Wen-Cheng
WC
Wei
Ching-Yang
CY
Wu
Ching-Feng
CF
Wu
Jui-Ying
JY
Fu
Ta-Wei
TW
Su
Sheng-Yueh
SY
Yu
Tsung-Chi
TC
Kao
Po-Jen
PJ
Ko
D000465:Algorithms; D016121:Brachiocephalic Veins; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000379:methods; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004358:Drug Therapy / Q000379:methods; D004868:Equipment Failure; D019544:Equipment Failure Analysis; D005260:Female; D006406:Hematoma / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D011030:Pneumothorax / Q000209:etiology / Q000517:prevention & control*; D015203:Reproducibility of Results; D012189:Retrospective Studies; D013624:Taiwan; D016896:Treatment Outcome; D016748:Venous Cutdown / Q000009:adverse effects* / Q000379:methods